Women With Early Breast Cancer To Receive The Most Up-to-date Information Available, Australia

National Breast and Ovarian Cancer Centre (NBOCC) has now released the eagerly anticipated revised version of its Guide for women with early breast cancer. The comprehensive, 200 page resource provides information to support women with early breast cancer* in making decisions about their treatment and care, as well as advice for family and friends. The […]

Cephalon Response To NICE Guidance On Advanced Breast Cancer Treatment Published 25 February 2009, UK

Liz Hardaker, medical director of Cephalon UK. “We are disappointed and surprised that NICE has not taken this opportunity to distinguish between different forms of anthracycline treatment; specifically the use of liposomal-encapsulated doxorubicin. “Myocet, in combination with cyclophosphamide, is indicated for the first line treatment of metastatic breast cancer in women (SmPC). A number of […]

Systematic Estimation Of Breast Cancer Risk Appears Justified In Postmenopausal Women

Screening for breast cancer risk in all postmenopausal women, using a combination of risk factors and breast density, can identify women at high risk of disease, according to systematic literature reviews and meta-analyses reported in the March 10 online issue of the Journal of the National Cancer Institute. The reviews and meta-analyses also support the […]

Herceptin Proven To Benefit Women With HER2 Positive Early Breast Cancer Latest Results From The HERA Study

Study confirms Herceptin’s promise of extra years of living cancer free The Breast International Group (BIG) in collaboration with Roche announced that women with HER2 positive early breast cancer continue to benefit from Herceptin (trastuzumab) several years after treatment completion and as a result enjoy a longer life disease free. The patients were treated for […]

Pitt School Of Nursing To Sponsor Breast Cancer Conference

The University of Pittsburgh School of Nursing will host a free conference for women living with metastatic breast cancer. Adam Brufsky, M.D., Ph.D., co-director of the Magee Breast Cancer Program of UPMC Cancer Centers and medical director of the Women’s Cancer Center at Magee-Womens Hospital of UPMC, will discuss current and potential treatment options for […]

In Postmenopausal Women Systematic Estimation Of Breast Cancer Risk Appears Justified

Screening for breast cancer risk in all postmenopausal women, using a combination of risk factors and breast density, can identify women at high risk of disease, according to systematic literature reviews and meta-analyses reported in the March 10 online issue of the Journal of the National Cancer Institute. The reviews and meta-analyses also support the […]

Biomoda Approved To Begin Screening Veterans For Lung Cancer

Biomoda, Inc. (OTCBB: BMOD), a medical diagnostics company based in Albuquerque, received approval from an independent Institutional Review Board (IRB) to begin Phase I clinical trials of its cytology-based screening technology for early detection of cancer. IRB review protects research subjects by reviewing the study protocol to make sure it adheres to U.S. Food and […]

Study Shows MicroRNA-Based Diagnostic Identifies Squamous Lung Cancer With 96% Sensitivity

Rosetta Genomics Ltd. (Nasdaq:ROSG) and collaborators announced the results of a research study, showing for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity. The study, posted on the Journal of Clinical Oncology’s Web site,[1] was carried out in collaboration with researchers at Columbia University, NYU Cancer […]

MicroRNA-Based Diagnostic Identifies Squamous Lung Cancer With 96 Percent Sensitivity

A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer Institute at NYU Langone Medical Center, one of the authors of the study published on-line ahead of print in the Journal of Clinical Oncology. […]

Twin Nanoparticle Shown Effective At Targeting, Killing Breast Cancer Cells

Breast cancer patients face many horrors, including those that arise when fighting the cancer itself. Medications given during chemotherapy can have wicked side effects, including vomiting, dizziness, anemia and hair loss. These side effects occur because medications released into the body target healthy cells as well as tumor cells. The trick becomes how to deliver […]